Fractionated LINAC-SBRT for Adrenal Gland Metatases: Dose-Dependence of Therapy Results (2018) Knippen S, Burjakow K, Putz F, Achterberg N, Lettmaier S, Fietkau R Conference contribution Impact of hypo- and normofractionated radiation on cell death and senescence of HNSCC-cells of different HPV-Status (2018) Wild K, Peitz L, Rieckmann T, Fietkau R, Frey B, Gaipl U Conference contribution Immune modulation by low dose radiation therapy-results from 70 patients followed up in the IMMO-LDRT01 study (2018) Donaubauer AJ, Gryc T, Becker I, Harrer A, Rühle PF, Ott OJ, Fietkau R, et al. Conference contribution GLIO-CMV-01: Identification of immune biomarkers for CMV-related encephalitis during radiotherapy of the brain (2018) Donaubauer AJ, Becker I, Rühle PF, Goerig N, Pohn A, Winkler T, Korn K, et al. Conference contribution Enhancing the Effect of Combination Therapy with the PARP Inhibitor Talazoparib and ionizing Radiation on Melanoma Cell Lines (2018) Proebstle S, Jost T, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Investigation of a radioprotective Effect of the Kinase Inhibitor Palbociclib on Melanoma Cells in a 3D Cell Culture Model (2018) Jost T, Buerkel F, Proebstle S, Hecht M, Fietkau R, Distel L Conference contribution Inflammatory Cells in HPV positive and negative Head and Neck Tumors (2018) Distel L, Haderlein M, Farhoumand D, Fietkau R, Hecht M Conference contribution Essential role of radiation therapy for the treatment of pancreatic cancer : Novel study concepts and established treatment recommendations (2018) Dobiasch S, Goerig N, Fietkau R, Combs SE Journal article Examination of Gold Marker Detection in Tracking Treatments of Liver Cancer Patients using Vero SBRT System (2018) Ziegler M, Brandt T, Lettmaier S, Strnad V, Fietkau R, Bert C Conference contribution Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies (2018) Rueckert M, Fietkau R, Frey B, Hecht M, Gaipl U, Deloch L Journal article, Review article